217 related articles for article (PubMed ID: 30443289)
1. Biothiols and oxidative stress markers and polymorphisms of
Prendecki M; Florczak-Wyspianska J; Kowalska M; Ilkowski J; Grzelak T; Bialas K; Wiszniewska M; Kozubski W; Dorszewska J
Oncotarget; 2018 Oct; 9(81):35207-35225. PubMed ID: 30443289
[TBL] [Abstract][Full Text] [Related]
2. Expression and polymorphisms of gene 8-oxoguanine glycosylase 1 and the level of oxidative DNA damage in peripheral blood lymphocytes of patients with Alzheimer's disease.
Dorszewska J; Kempisty B; Jaroszewska-Kolecka J; Rózycka A; Florczak J; Lianeri M; Jagodziński PP; Kozubski W
DNA Cell Biol; 2009 Nov; 28(11):579-88. PubMed ID: 19630534
[TBL] [Abstract][Full Text] [Related]
3. Definitive roles of TOMM40-APOE-APOC1 variants in the Alzheimer's risk.
Kulminski AM; Philipp I; Shu L; Culminskaya I
Neurobiol Aging; 2022 Feb; 110():122-131. PubMed ID: 34625307
[TBL] [Abstract][Full Text] [Related]
4. APOE ɛ4 allele and TOMM40-APOC1 variants jointly contribute to survival to older ages.
Kulminski AM; Jain-Washburn E; Philipp I; He L; Loika Y; Loiko E; Bagley O; Ukraintseva S; Yashin A; Arbeev K; Stallard E; Feitosa MF; Schupf N; Christensen K; Culminskaya I
Aging Cell; 2022 Dec; 21(12):e13730. PubMed ID: 36330582
[TBL] [Abstract][Full Text] [Related]
5. TOMM40 rs10524523 polymorphism's role in late-onset Alzheimer's disease and in longevity.
Maruszak A; Pepłońska B; Safranow K; Chodakowska-Żebrowska M; Barcikowska M; Zekanowski C
J Alzheimers Dis; 2012; 28(2):309-22. PubMed ID: 22008263
[TBL] [Abstract][Full Text] [Related]
6.
Kulminski AM; Jain-Washburn E; Philipp I; Loika Y; Loiko E; Culminskaya I
Alzheimers Dement (Amst); 2024; 16(2):e12600. PubMed ID: 38912305
[TBL] [Abstract][Full Text] [Related]
7. Association of common variants in TOMM40/APOE/APOC1 region with human longevity in a Chinese population.
Lin R; Zhang Y; Yan D; Liao X; Gong G; Hu J; Fu Y; Cai W
J Hum Genet; 2016 Apr; 61(4):323-8. PubMed ID: 26657933
[TBL] [Abstract][Full Text] [Related]
8. Association Analysis of Polymorphisms in TOMM40, CR1, PVRL2, SORL1, PICALM, and 14q32.13 Regions in Colombian Alzheimer Disease Patients.
Ortega-Rojas J; Morales L; Guerrero E; Arboleda-Bustos CE; Mejia A; Forero D; Lopez L; Pardo R; Arboleda G; Yunis J; Arboleda H
Alzheimer Dis Assoc Disord; 2016; 30(4):305-309. PubMed ID: 27023435
[TBL] [Abstract][Full Text] [Related]
9. Associations between TOMM40 Poly-T Repeat Variants and Dementia in Cases with Parkinsonism.
Lindqvist D; Prokopenko I; Londos E; Middleton L; Hansson O
J Parkinsons Dis; 2016; 6(1):99-108. PubMed ID: 26756745
[TBL] [Abstract][Full Text] [Related]
10. The levels of 7,8-dihydrodeoxyguanosine (8-oxoG) and 8-oxoguanine DNA glycosylase 1 (OGG1) - A potential diagnostic biomarkers of Alzheimer's disease.
Sliwinska A; Kwiatkowski D; Czarny P; Toma M; Wigner P; Drzewoski J; Fabianowska-Majewska K; Szemraj J; Maes M; Galecki P; Sliwinski T
J Neurol Sci; 2016 Sep; 368():155-9. PubMed ID: 27538622
[TBL] [Abstract][Full Text] [Related]
11. TOMM40, APOE, and APOC1 in primary progressive aphasia and frontotemporal dementia.
Seripa D; Bizzarro A; Pilotto A; Palmieri O; Panza F; D'Onofrio G; Gravina C; Archetti S; Daniele A; Borroni B; Padovani A; Masullo C
J Alzheimers Dis; 2012; 31(4):731-40. PubMed ID: 22710912
[TBL] [Abstract][Full Text] [Related]
12. Expression of 8-oxoguanine DNA glycosylase 1 (OGG1) and the level of p53 and TNF-αlpha proteins in peripheral lymphocytes of patients with Alzheimer's disease.
Dezor M; Dorszewska J; Florczak J; Kempisty B; Jaroszewska-Kolecka J; Rozycka A; Polrolniczak A; Bugaj R; Jagodzinski PP; Kozubski W
Folia Neuropathol; 2011; 49(2):123-31. PubMed ID: 21845541
[TBL] [Abstract][Full Text] [Related]
13. Association of
Chen W; Zhou X; Duan Y; Zou T; Liu G; Ying X; Wang Q; Duan S
Exp Ther Med; 2018 Oct; 16(4):3135-3142. PubMed ID: 30214536
[TBL] [Abstract][Full Text] [Related]
14. The influence of APOE and TOMM40 polymorphisms on hippocampal volume and episodic memory in old age.
Ferencz B; Laukka EJ; Lövdén M; Kalpouzos G; Keller L; Graff C; Wahlund LO; Fratiglioni L; Bäckman L
Front Hum Neurosci; 2013; 7():198. PubMed ID: 23734114
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in APOE cluster region and Alzheimer's disease risk.
Cervantes S; Samaranch L; Vidal-Taboada JM; Lamet I; Bullido MJ; Frank-García A; Coria F; Lleó A; Clarimón J; Lorenzo E; Alonso E; Sánchez-Juan P; Rodríguez-Rodríguez E; Combarros O; Rosich M; Vilella E; Pastor P
Neurobiol Aging; 2011 Nov; 32(11):2107.e7-17. PubMed ID: 21752496
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment.
Chico L; Simoncini C; Lo Gerfo A; Rocchi A; Petrozzi L; Carlesi C; Volpi L; Tognoni G; Siciliano G; Bonuccelli U
Free Radic Res; 2013 Aug; 47(8):569-76. PubMed ID: 23668794
[TBL] [Abstract][Full Text] [Related]
17. Superior Frontal Gyrus
Bezuch N; Bradburn S; Robinson AC; Pendleton N; Payton A; Murgatroyd C
J Alzheimers Dis Rep; 2021 Apr; 5(1):275-282. PubMed ID: 34113784
[TBL] [Abstract][Full Text] [Related]
18. The effect of TOMM40 on spatial navigation in amnestic mild cognitive impairment.
Laczó J; Andel R; Vyhnalek M; Matoska V; Kaplan V; Nedelska Z; Lerch O; Gazova I; Moffat SD; Hort J
Neurobiol Aging; 2015 Jun; 36(6):2024-33. PubMed ID: 25862420
[TBL] [Abstract][Full Text] [Related]
19. Genome-Wide Association and Mechanistic Studies Indicate That Immune Response Contributes to Alzheimer's Disease Development.
Liu C; Chyr J; Zhao W; Xu Y; Ji Z; Tan H; Soto C; Zhou X;
Front Genet; 2018; 9():410. PubMed ID: 30319691
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms.
Mastaglia FL; Rojana-udomsart A; James I; Needham M; Day TJ; Kiers L; Corbett JA; Saunders AM; Lutz MW; Roses AD;
Neuromuscul Disord; 2013 Dec; 23(12):969-74. PubMed ID: 24103330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
